Posted inGenetics Updated Amplification Tool Rapidly Detects Mycoplasma June 10, 2026 Nucleic acid amplification techniques (NAAT) are recommended by pharmacopoeias in the United States, the EU, and Japan as an alternative…
Posted inGenetics Innovative Tech Testing in Response to GMP Revisions June 10, 2026 Recent revisions to EU manufacturing guidelines are changing how drug makers test processing technologies, according to the author of a…
Posted inGenetics In Silico Devices May Improve Drug Manufacturability June 10, 2026 Using in silico tools to augment physical experiments can help identify manufacturability issues early in development. That’s according to an…
Posted inGenetics Gorilla Adenovirus Brings Natural Edge to Cancer Therapy June 10, 2026 When ReiThera’s scientists first turned to a gorilla-derived adenovirus, they were thinking about vaccines. What they found instead might reshape…
Posted inGenetics mRNA Tails Play Key Role in Folding Regulatory Proteins June 10, 2026 Credit: Kateryna Kon / Science Photo Library / Getty images mRNA 3′ UTRs have hundreds of highly conserved nucleotides, but…
Posted inGenetics 10x Genomics Acquires Proteintech Genomics, Expanding Proteomics Capablities June 10, 2026 10x Genomics has acquired Proteintech Genomics for an undisclosed price, in a deal driven by the buyer’s commitment to expanding…
Posted inGenetics The State of Biologics Testing Report 2026 June 10, 2026 The success of modern biologics depends not only on groundbreaking science but on the robustness, speed, and credibility of the…
Posted inGenetics T-Cell Synapse Formation Is Restrained by PTPN22–PSTPIP1 Signaling June 10, 2026 Fluorescent images of F-actin, WASp, WASH, and PSTPIP-1 in WT and PTPN22 KO Jurkat cells after 10 min of activation…
Posted inGenetics First-in-Human Trial Reports Promising Dual Lassa–Rabies Vaccine Data June 9, 2026 Credit: Kuzmik_A / iStock / Getty Images Plus Researchers at the University of Maryland School of Medicine’s Center for Vaccine…
Posted inGenetics Incyte to Acquire Vega Therapeutics for Up-to-$2B, Growing Hematology Pipeline with Phase III VWD Candidate June 9, 2026 Credit: iLexx/Getty Images Incyte has agreed to acquire Vega Therapeutics for up to $2 billion, the companies said, in a…